We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Financials | 14.89% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Loews
L
$24.3B
| $7.63M | 0.02% |
148,177
-149,860
| -50% | -$7.74M |
|
502
AES
AES
$10.6B
| $7.62M | 0.02% |
466,396
-776,539
| -62% | -$12.5M |
|
503
Equifax
EFX
$20.3B
| $7.54M | 0.02% |
53,613
-523
| -1% | -$73.7K |
|
504
Expeditors International
EXPD
$22.9B
| $7.5M | 0.02% |
100,908
-166,941
| -62% | -$12.2M |
|
505
McCormick & Company Non-Voting
MKC
$13.4B
| $7.49M | 0.02% |
95,856
-1,070
| -1% | -$86K |
|
506
Freeport-McMoran
FCX
$90B
| $7.49M | 0.02% |
781,948
-14,670
| -2% | -$151K |
|
|
IRCP
507
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $7.49M | 0.02% |
2,473,614
+9,677
| +0.4% | +$36.6K |
|
508
J.M. Smucker
SJM
$12.6B
| $7.47M | 0.02% |
67,870
-14,908
| -18% | -$1.66M |
|
509
Church & Dwight Co
CHD
$23.1B
| $7.45M | 0.02% |
98,974
-168,480
| -63% | -$12.8M |
|
510
Broadridge
BR
$17.2B
| $7.41M | 0.02% |
59,550
-77,183
| -56% | -$9.94M |
|
511
Take-Two Interactive
TTWO
$43B
| $7.4M | 0.02% |
59,045
+4,880
| +9% | +$609K |
|
512
Keysight
KEYS
$54.5B
| $7.31M | 0.02% |
75,181
+998
| +1% | +$92.5K |
|
|
BSMX
513
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $7.27M | 0.02% |
1,153,037
-323,200
| -22% | -$2.22M |
|
514
Neurocrine Biosciences
NBIX
$17.7B
| $7.27M | 0.02% |
80,688
-19,608
| -20% | -$1.83M |
|
|
ANSS
515
DELISTED
Ansys
ANSS
| $7.25M | 0.02% |
32,763
-30,041
| -48% | -$6.33M |
|
516
C.H. Robinson
CHRW
$22B
| $7.16M | 0.02% |
84,466
-48,720
| -37% | -$4.09M |
|
517
SL Green Realty
SLG
$3.88B
| $7.15M | 0.02% |
90,337
-93,964
| -51% | -$7.31M |
|
518
Align Technology
ALGN
$12B
| $7.03M | 0.02% |
38,856
+992
| +3% | +$206K |
|
519
JD.com
JD
$40.8B
| $7M | 0.02% |
248,180
-123,459
| -33% | -$3.73M |
|
520
Eastman Chemical
EMN
$7.8B
| $7M | 0.02% |
94,802
-80,974
| -46% | -$5.81M |
|
521
Bunge Global
BG
$23.6B
| $6.95M | 0.02% |
122,708
+4,602
| +4% | +$257K |
|
522
Viatris
VTRS
$20.1B
| $6.92M | 0.02% |
349,791
-177,895
| -34% | -$3.49M |
|
523
Lincoln National
LNC
$7.91B
| $6.83M | 0.02% |
113,275
-3,598
| -3% | -$215K |
|
524
Everest Group
EG
$15.2B
| $6.81M | 0.02% |
25,594
-736
| -3% | -$186K |
|
525
Mettler-Toledo International
MTD
$26.8B
| $6.8M | 0.02% |
9,660
-149
| -2% | -$109K |
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.